Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure

American Journal of Kidney Diseases

Volumn 30, Issue 4, 1997, Pages 532-541

  Ahluwalia, Naman ^a   Skikne, Barry S ^a,b   Savin, Virginia ^a   Chonko, Arnold ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Erythropoietin; Iron depletion; Renal failure

Indexed keywords

FERRITIN; IRON; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN RECEPTOR;

ADULT; AGED; ANEMIA; ARTICLE; CHRONIC DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; FEMALE; HEMATOLOGICAL PARAMETERS; HEMODIALYSIS; HUMAN; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MALE; RETICULOCYTE COUNT; TREATMENT OUTCOME;

EID: 0030846076     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(97)90313-9     Document Type: Article

References (34)

1. Eschbach JW, Abdulhadi MH, Browne JK, Delano BG, Downing MR, Egrie JC, Evans RW, Friedman EA, Graber SE, Haley R, Korbet S, Krantz SB, Lundin P, Nissenson AR, Ogden DA, Paganini EP, Rader B, Rutsky EA, Stivelman J, Stone WJ, Teschan P, Van Stone JC, Van Wyck DB, Zuckerman K, Adamson JW: Recombinant human erythropoietin in anemic patients with end-stage renal disease: Results of a phase III multicenter clinical trial. Ann Intern Med 111:992-1000, 1989
2. Skikne BS, Cook JD: Influence of recombinant human erythropoietin on iron metabolism in healthy subjects, in Bauer C, Koch KM, Scigalla P, Wieczorek L (eds): Erythropoietin: Molecular Physiology and Clinical Applications. New York, NY, Marcel Dekker, 1993, pp 177-187
3. Van Wyck DB, Stivelman JC, Ruiz J, Kirlin LF, Katz MA, Ogden DA: Iron status in patients receiving erythropoietin for dialysis associated anemia. Kidney Int 35:712-716, 1989
4. Van Wyck DB: The challenge of iron deficiency during r-HuEPO therapy. Semin Dial 2:135-136, 1989
5. Morris KP, Watson S, Reid MM, Hamilton PJ, Coulthard MG: Assessing iron status in children with chronic renal failure on erythropoietin: Which measurements should we use. Pediatr Nephrol 8:51-56, 1994
6. Kalantar-Zadeh K, Hofften B, Wunsch H, Fink H, Kleiner M, Luft FC: Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era. Am J Kidney Dis 26:292-299, 1995
7. Huff RL, Feller DO: Relation of circulating red cell volume to body density and obesity. J Clin Invest 35:1-10, 1956
8. Houwen B: Reticulocyte maturation. Blood Cells 18:167-186, 1992
9. Hastka J, Lasserre JJ, Schwarzbeck A, Strauch M: Washing erythrocytes to remove interferants in measurements of zinc protoporphyrin by front-face hematofluorometry. Clin Chem 38:2184-2189, 1992
10. Skikne BS: A commercial electrochemical method evaluated for measurement of iron status. Clin Chem 33:1645-1647, 1987
11. International Committee for Standardization in Haematology: The measurement of total and unsaturated iron-binding capacity in serum. Br J Haematol 38:281-287, 1978
12. Flowers CA, Kuizon M, Beard JL, Skikne BS, Covell AM, Cook JD: A serum ferritin assay for prevalence studies of iron deficiency. Am J Hematol 23:141-151, 1986
13. Flowers CH, Skikne BS, Covell AM, Cook JD: The clinical measurement of serum transferrin receptor. J Lab Clin Med 114:368-377, 1989
14. Whittaker P, Skikne BS, Covell AM, Flowers C, Cooke A, Lynch SR, Cook JD: Duodenal iron proteins in idiopathic hemochromatosis. J Clin Invest 83:261-267, 1989
15. Brunati C, Piperno A, Guastoni C, Perrino ML, Civati G, Teatini U, Perego A, Fiorelli G, Minetti L: Erythrocyte ferritin in patients on chronic hemodialysis treatment. Nephron 54:219-223, 1990
16. Fletcher RM, Fletcher SW, Wagner EH: Clinical Epidemiology (ed 3). Philadelphia, PA, Williams & Wilkins, 1996
17. Dessypris EN, Graber SE, Krantz SB, Stone WJ: Effects of recombinant erythropoietin on the concentration and cycling status of human marrow hematopoietic progenitor cells in vivo. Blood 72:2060-2062, 1988
18. Krantz SB: Erythropoietin. Blood 77:419-434, 1991
19. Beguin Y, Huebers HA, Josephson B, Finch CA: Transferrin receptors in rat plasma. Proc Natl Acad Sci U S A 85:637-640, 1988
20. Kohgo Y, Niitsu Y, Kondo H, Kato I, Isushima N, Sasaki K, Hirayama M, Numata T, Nishisato T, Urushizaki I: Serum transferrin receptor as a new index of erythropoiesis. Blood 70:1955-1958, 1987
21. Huebers HA, Beguin Y, Pootrakul P, Einspahr D, Finch CA: Intact transferrin receptors in human plasma and their relation to erythropoiesis. Blood 75:102-107, 1990
22. Cazzola M: Annotation: New tools for clinical evaluation of erythron function in man. Br J Haematol 80:278-284, 1992
23. Rouault T, Rao K, Harford J, Mattia E, Klausner RD: Hemin, chelatable iron, and the regulation of transferrin receptor biosynthesis. J Biol Chem 260:14862-14866, 1985
24. Skikne BS, Flowers CH, Cook JD: Serum transferrin receptor: A quantitative measure of tissue iron deficiency. Blood 75:1870-1876, 1990
25. Cook JD, Baynes RD, Skikne BS: Iron deficiency and the measurement of iron status. Nutr Res Rev 5:189-202, 1992
26. Lee LG, Chen CH, Chin LA: Thiazole orange: A new dye for reticulocyte analysis. Cytometry 7:508-517, 1986
27. Beguin Y, Loo M, R'Zik S, Sautois B, Lejeune F, Roriye G, Fillet G: Quantative assessment of erythropoiesis in hemodialysis patients demonstrates gradual expansion of erythroblasts during constant treatment with recombinant human erythropoietin. Br J Haematol 89:17-23, 1995
28. Skikne BS, Cook JD: Effect of enhanced erythropoiesis on iron absorption. J Lab Clin Med 120:746-751, 1992
29. Bezwoda WR, Derman DP, Bothwell TH, MacPhail AP, Torrance JD, Milne FJ, Meyers AM, Levin J: Iron absorption in patients on regular dialysis therapy. Nephron 28:289-293, 1981
30. Eschbach JW, Cook JD, Scribner BH, Finch CA: Iron balance in hemodialysis patients. Ann Intern Med 87:710-713, 1977
31. Wingard RL, Parker RA, Ismail N, Hakim RM: Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin. Am J Kidney Dis 25:433-439, 1995
32. Brugnara C, Chambers LA, Malynn E, Goldberg MA, Kruskall MS: Red blood cell regeneration induced by subcutaneous recombinant erythropoietin: Iron-deficient erythropoiesis in iron-replete subjects. Blood 81:956-964, 1993
33. Caravaca F, Vagace JM, Aparicio A, Groiss J, Pizarro JL, Alonso N, Garcia MC, Arrobas M, Cubero J, Esparrago J, Sanchez-Casado E: Assessment of iron status by erythrocyte ferritin in uremic patients with or without recombinant human erythropoietin therapy. Am J Kidney Dis 20:249-254, 1992
34. Macdougall IC, Cavill I, Hulme B, Bain B, McGregor E: Detection of functional iron deficiency during erythropoietin treatment: A new approach. BMJ 304:225-226, 1992